Itovebi: payments to doctors
Payments that named Itovebi as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $360K
- Providers
- 3,078
- Transactions
- 4,430
- Average per transaction
- $81
The per-transaction average — $81 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,078 providers the average total is $117, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Genentech USA, Inc. | $297,493 | 82.7% |
| Genentech, Inc. | $55,791 | 15.5% |
| Hoffmann-la Roche Limited | $6,560 | 1.8% |